San Luis Obispo, CA, United States of America

Jan Segnitz

USPTO Granted Patents = 5 

 

Average Co-Inventor Count = 4.8

ph-index = 3

Forward Citations = 34(Granted Patents)


Location History:

  • San Luis Obispo, CA (US) (2017 - 2018)
  • San Jose, CA (US) (2022)

Company Filing History:


Years Active: 2017-2025

Loading Chart...
Loading Chart...
5 patents (USPTO):

Title: Innovations by Jan Segnitz in Uterine Hemorrhage Control

Introduction

Jan Segnitz is an accomplished inventor based in San Luis Obispo, California. He has made significant contributions to medical technology, particularly in the field of uterine hemorrhage control. With a total of five patents to his name, Segnitz is recognized for his innovative solutions that address critical health issues.

Latest Patents

One of Segnitz's latest patents is a postpartum uterine hemorrhage device. This anti-hemorrhaging device features an elongate body, a flexible looped segment, a shield, and an inflatable seal. The elongate body is designed to attach to a vacuum source, while the flexible looped segment is configured to be placed in the uterus. When activated, the vacuum source pulls vacuum through the holes in the looped segment, collapsing the uterus upon insertion. The shield prevents tissue from occluding the holes when vacuum is applied, and the inflatable seal is designed to seal the uterus effectively.

Another notable patent is the uterine hemorrhage controlling system and method. This insertable device is designed to control uterine hemorrhaging after birth by facilitating contractile movement of the uterus. It comprises a tube with a connecting portion and a suction portion, along with a seal positioned along the length of the connecting portion. Upon insertion, the seal forms a barrier between the vaginal opening and the uterus. The suction portion generates negative pressure within the uterus, providing a uniform mechanical stimulus to the uterine wall to facilitate tamponade and contractile movement of the tissue.

Career Highlights

Throughout his career, Jan Segnitz has worked with several innovative companies, including Alydia Health, Inc. and Inpress Technologies, Inc. His work in these organizations has allowed him to develop and refine his groundbreaking inventions aimed at improving women's health.

Collaborations

Segnitz has collaborated with talented individuals in the field, including Amelia Michele Degenkolb and Davis Reed Carlin. These partnerships have contributed to the advancement of his inventions and the overall impact on medical technology.

Conclusion

Jan Segnitz's contributions to the field of uterine hemorrhage control through his innovative patents demonstrate his commitment to improving healthcare solutions. His work continues to influence the medical community and offers hope for better outcomes in women's health.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…